NCB busts Delhi-Kashmir pharma drug network; 5 lakh tablets seized, 4 arrested
Synopsis
Key Takeaways
The Narcotics Control Bureau (NCB), operating through its Jammu Zonal Unit in coordination with the Delhi Zonal Unit, has dismantled an interstate pharmaceutical drug trafficking network that was funnelling controlled substances from Delhi to the Kashmir Valley. Four individuals have been arrested and over five lakh tablets, capsules, and bottles of pharmaceutical preparations have been seized in a multi-city operation conducted between 16 and 19 November.
How the Operation Unfolded
Acting on specific intelligence, NCB Jammu personnel intercepted a Srinagar-bound passenger bus near Mada Toll Plaza in Chenani, Udhampur district, in the early hours of 16 November. A passenger — identified as a resident of Bhaderwah in Doda district — was found carrying approximately 7 kg of codeine-based cough syrup (CBCS). A case was immediately registered under the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985.
Subsequent investigation in the Kashmir Valley led to the arrest of the suspected principal recipient of the consignment, a resident of Anantnag district. Investigators then traced the supply chain northward to its source in the capital.
Delhi Raid Uncovers Clandestine Godown
On 18 November, joint teams from the NCB Jammu and Delhi Zonal Units apprehended further individuals linked to the supply operation in Delhi and recovered 356 bottles of CBCS. Leads from those arrests pointed to a concealed warehouse operating out of rented premises in Shahdara, Delhi.
Searches conducted on 18 and 19 November at the Shahdara godown resulted in the seizure of more than five lakh tablets, capsules, and bottles of pharmaceutical preparations containing tramadol hydrochloride, alprazolam, nitrazepam, and codeine — all controlled substances with significant abuse potential.
Scope of the Investigation
According to the NCB, investigators are now working to establish precisely how and where the seized cough syrup was diverted from legitimate pharmaceutical supply channels. The agency said it is pursuing leads related to upstream suppliers, downstream distributors, and the financial networks sustaining the operation — with the stated objective of preventing further diversion at the source.
This comes amid a broader national push under the Nasha Mukt Bharat campaign, which has seen the NCB intensify surveillance on pharmaceutical drug diversion — a category of narcotics trafficking that exploits legal supply chains rather than smuggling routes, making it harder to detect and prosecute.
NCB Appeal to Citizens
The NCB has urged members of the public to report credible information on drug trafficking and pharmaceutical diversion through the national narcotics helpline, MANAS (1933), on a confidential basis. The agency described public cooperation as critical to sustaining enforcement gains under the Nasha Mukt Bharat framework.
Investigators are expected to widen the probe as financial and supply-chain links are examined further in the coming days.